Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Fresenius Wins U.S. Appeal Over Baxter Hemodialysis Patent

July 2 (Bloomberg) -- Fresenius Medical Care AG won a U.S. appeals court ruling today that will end a patent-infringement claim brought against it by Baxter International Inc. over kidney dialysis machines.

The U.S. Patent and Trademark Office has canceled the Baxter patent after a review while the civil suit was still pending, so there is no longer any basis for Baxter’s claim, the U.S. Court of Appeals for the Federal Circuit ruled in Washington today. The opinion was posted on the court’s website.

Link to Company News:{FME GR <Equity> CN <GO>} Link to Company News:{BAX US <Equity> CN <GO>} Link to Company News:{1001L US <Equity> CN <GO>}

To contact the reporter on this story: Susan Decker in Washington at

To contact the editor responsible for this story: Bernard Kohn at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.